Thromboxane B2-d4

• Description :

  Thromboxane B2-D4 is the deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1][2].

• UNSPSC :

  12352005

• Hazard Statement :

  H225, H319, H336

• Target :

  Isotope-Labeled Compounds

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Others

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Concentration :

  267.02 μM * 250 μL in Methyl acetate

• Purity :

  99.9

• Solubility :

  DMSO : ≥ 25 mg/mL

• Smiles :

  O=C(O)CC([2H])([2H])C([2H])([2H])/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H](O)C[C@@H]1O

• Molecular Formula :

  C20H30D4O6

• Molecular Weight :

  374.51

• Precautions :

  H225, H319, H336

• References & Citations :

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  Solution, -20°C, 2 years

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported

• CAS Number :

  [1346112-79-5]